Global Spirometer Market Analysis/Forecasts, 2021-2022 & 2028: Technological Shift Toward Smartphone-Based Data Collection & Increasing Government Initiatives - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Spirometer Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Technology, and Application" report has been added to ResearchAndMarkets.com's offering.

The spirometers market is expected to grow from US$ 893.71 million in 2021 to US$ 1,907.36 million by 2028; it is estimated to grow at a CAGR of 11.5% from 2022 to 2028.

The spirometers market is growing owing to the higher adoption of home care products. The high growth potential in emerging markets and the development of miniaturized devices are among the crucial factors anticipated to provide growth opportunities to players operating in the spirometer home healthcare market.

Due to rising healthcare costs, many patients suffering from chronic respiratory diseases prefer to undergo treatments in-home care settings. Moreover, home spirometers are widely used to provide easy access to detailed information regarding lung function. For instance, a pilot study from Iran in 2018 suggested that home spirometry may be used in monitoring complications following lung transplant surgery.

Spirometry is also used before lung cancer surgery to predict how well a patient will tolerate the operation and manage it once a portion or lobe of a lung is removed. In addition, one such spirometer is alveoair. It is a personal spirometer designed for asthma, COPD, and cystic fibrosis patients to help quantify their lung health.

It enables patients to monitor their disease at home to help avoid attacks and unnecessary hospital visits. Alveoair is a clinically trialed spirometer that has completed its clinical trial in January 2021 and provides results at par with a hospital-grade spirometer.

Spirometers Market: Segmental Overview

The table-top spirometers segment holds the largest market share in 2022. However, the handheld segment is anticipated to register the highest CAGR during the forecast period as the small, lightweight, easily portable, and handheld spirometers are becoming universal in the industry.

In 2022, the flow segment holds the largest market share. However, the peak flow segment is expected to register the highest CAGR from 2022 to 2028 due to its working pattern as patients blow into a mouthpiece at one end of the device, and the peak flow meter measures the force of the air flowing out of the lungs in liters per minute.

In 2022, the chronic obstructive pulmonary disease segment holds the largest market share. Moreover, the same segment is expected to register the highest CAGR from 2022 to 2028, owing to the growing prevalence of COPD and the adoption of easy diagnosis of COPD offered by spirometry.

Market Opportunities of Spirometers Market

Various organizations such as ''Global Initiative for Chronic Obstructive Lung Disease (GOLD)'' formed by WHO along with the US government to improve the diagnosis and treatment of chronic obstructive lung disease globally have made various initiatives and guidelines to improve care for chronic obstructive pulmonary disease.

These guidelines defined COPD as post-bronchodilator airway obstruction. As most patients with risk factors for COPD are seen by primary care providers, considerable funding has been directed toward encouraging them to find cases of COPD in their practice. Additionally, spirometry testing is recommended by the GOLD as the preferred method for diagnosing COPD.

Moreover, the WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) initiative and the United Nations 2030 Agenda for Sustainable Development also focuses on COPD management. Also, the WHO Package of Essential Non-communicable Disease Interventions (PEN) includes protocols for assessing, diagnosing, and managing chronic respiratory diseases (asthma and COPD) and modules on healthy lifestyle counseling.

Furthermore, large direct-to-consumer (DTC) campaigns in the US urge smokers with respiratory disease symptoms to ask their doctor for a spirometry test. Therefore, continuous government initiatives are likely to modernize and offer opportunities for the growth of the spirometer market during the forecast period.

Key Market Dynamics

Market Drivers

• Increasing Prevalence of Respiratory Diseases
• Increasing Preference of Home Care Products

Market Restraints

• Unfavorable Reimbursement Scenario

Market Opportunities

• Increasing Government Initiatives

Future Trends

• Technological Shift Toward Smartphone-Based Data Collection

Company Profiles

• Jones Medical Instrument Company
• Benson Medical Instruments Co.
• NUVOAIR U.S, INC. (NUVOAIR AB)
• Teleflex Incorporated
• VYAIRE MEDICAL, INC.
• COSMED Srl
• Depisteo LLC.
• Henry Schein, Inc.
• Baxter International Inc.
• ICU Medical Inc.

For more information about this report visit https://www.researchandmarkets.com/r/qrdag9